Tag: Drug naming

The global monoclonal antibody therapeutics market was valued at over $233 billion in 2023 and is projected to grow significantly [1.4.7]. For clinicians and patients wondering, *How can you recognize a monoclonal antibody drug?* The secret is systematically encoded in its generic name.

Over half of all commercially available antibiotics in use in 2003 were beta-lactam compounds. But **why are they called beta-lactams**? The answer lies in the unique four-membered ring structure at the core of these life-saving drugs.

According to the Institute for Safe Medication Practices (ISMP), sound-alike and look-alike drug names are a significant cause of medication errors. The search query for 'Duraline' is a perfect example of this potential confusion, as no such FDA-approved or medically recognized drug exists, but several similarly-named pharmaceuticals do.